Advertisement

H2-Rezeptorantagonisten — Abwägung von Nutzen und Risiko bei Intensivpatienten

  • R. Gugler
Conference paper

Zusammenfassung

Akute Streßläsionen des oberen Gastrointestinaltraktes gelten als besonderes Risiko bei intensivmedizinisch versorgten Patienten, doch schwanken die Angaben über die Häufigkeit ihres Auftretens zwischen wenigen Prozent und über 50% bei Patienten mit einem besonders hohen Risiko (Tryba et al. 1985). Der Versuch, das individuelle Risiko besser abschätzen zu können, hat zur Definition von Risikofaktoren geführt, von denen die wichtigsten in der folgenden Übersicht aufgeführt sind.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Basso N, Bagarani M, Materia A, Fiorani S, Lunardi P, Speranza V (1981) Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Am J Surg 141: 229–341CrossRefGoogle Scholar
  2. van den Berg B, van Blankenstein M (1982) The prevention of stress-induced upper gastrointestinal bleeding by ranitidine in critically ill patients. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Oxford Medicine Publishing Foundation, pp 263–268Google Scholar
  3. van den Berg B, van Blankenstein M (1985) Prevention of stress-induced upper gastrointestinal bleeding by Cimetidine in patients on assisted ventilation. Digestion 31: 1–8PubMedCrossRefGoogle Scholar
  4. Cheadle WG, Vitale GO, Mackie CR, Cuschieri A (1985) Prophylactic postoperative nasogastric decompression. A prospective study of its requirement and the influence of Cimetidine in 200 patients. Ann Surg 202: 361PubMedCrossRefGoogle Scholar
  5. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR (1986) Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Resp Dis 133: 792PubMedGoogle Scholar
  6. Daschner F, Just H, Vogel WM (1986) Erhöht Streßulcus-Prophylaxe das Pneumonierisiko bei Beatmung? Anästhesist 35: 325Google Scholar
  7. Ditschuneit H, Malvertheiner P (1981) Schleimhautläsionen im Magen-Darm-Trakt. Med Welt 33: 78Google Scholar
  8. Du Moulin GC, Paterson DG, Hedley-White J, Lisbon A (1982) Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1: 242–245PubMedGoogle Scholar
  9. Engelhardt D, Karl R, Kolb HJ, Inthorn D, König N, Büll U, Holzel D (1985) Vergleich von Cimetidin-Pirenzepin und Antacida zur Streßblutungsprophylaxe bei Intensivpatienten. Dtsch Med Wochenschr 23: 908CrossRefGoogle Scholar
  10. Feely J,Wilkinson GR, McAllister CB, Wood AJJ (1982) Increased toxicity and reduced clearance of lidocaine by Cimetidine. Am Intern Med 96: 592–594Google Scholar
  11. Friedman CJ, Oblinger MJ, Suratt PM, et al (1982) Prophylaxis of upper gastrointestinal haemorrhage in patients requiring mechanical ventilation. Crit Care Med 10: 316–319PubMedGoogle Scholar
  12. Groll A, Simon JB, Wigle RD, Taguchi K, Todd RJ, Depew WT (1986) Cimetidine prophylaxis for gastrointestinal bleeding in an intensive care unit. Gut 27: 135–140PubMedCrossRefGoogle Scholar
  13. Gugler R (1986) Zur Relevanz der Unterschiede zwischen H2-Rezeptorantagonisten. Int Welt 7: 216–222Google Scholar
  14. Halloran LG, Gayle E, Wheeler CB, Miller JD (1980) Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of Cimetidine. Am J Surg 139: 44–48PubMedCrossRefGoogle Scholar
  15. Hillman KM, Riordan T, O’Farrell SM, Tabaqchali S (1982) Colonization of the gastric content in critically ill patients. Crit Care Med 10: 444PubMedCrossRefGoogle Scholar
  16. Huchzermeyer H, Tryba M (1987) Wirksamkeit von H2-Antagonisten zur Streßblutungsprophylaxe. In: Tryba M (Hrsg) Rationale Streßblutungsprophylaxe. Thieme, StuttgartGoogle Scholar
  17. Inthorn D, Seide K (1985) Ursachen und Prognose des respiratorischen Versagens chirurgischer Intensivpatienten. MMW 127: 1006Google Scholar
  18. Khan F, Parekh A, Pantel S, Chitkara R, Rehman M, Goyal MB (1981) Results of gastric neutralization with hourly antacids and Cimetidin in 320 intubated patients with respiratory failure. Chest 79: 409PubMedCrossRefGoogle Scholar
  19. Kingsley AN (1985) Prophylaxis for acute stress ulcers. Am Surg 9: 545Google Scholar
  20. Lorenz W, Fischer M, Rhode H, Troidl H, Reimann HJ, Ohmann C (1980) Histamine and stress ulcer: new components in organizing a sequential trial on Cimetidine prophylaxis in seriously ill patients and definition of a special risk. Klin Wochenschr 58: 653–656PubMedCrossRefGoogle Scholar
  21. Luk GD, Summer WR, Messersmith JF, the MICU Staff, the Osler Housestaff, Hendrix TR (1982) Cimetidine and antacid in prophylaxis of acute gastrointestinal bleeding. Gastroenterology 82: 1121Google Scholar
  22. MacDougall BRD, Wilhams R (1978) H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure. Gastroenterology 74: 464–465PubMedGoogle Scholar
  23. MacDougall BRD, Bailey RJ, Wilhams R (1977) H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 19: 617CrossRefGoogle Scholar
  24. Martin LF, Max MH, Polk HC (1980) Failure of gastric pH control by antacids or Cimetidine in the critically ill: a valid sign of sepsis. Surg 88: 59Google Scholar
  25. Mauritz W, Graninger W, Schindler I, Karner J, Zadrobilek E, Spora P (1985) Keimflora in Magensaft und Bronchialsekret bei langzeitbeatmeten Intensivpatienten. Anaesthesist 34: 203–207PubMedGoogle Scholar
  26. McElwee HP, Sirinek KR, Levine BA (1979) Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury. Surg 86: 620Google Scholar
  27. Moscona R, Kaufman T, Jacobs R, Hirshowitz B (1985) Prevention of gastrointestinal bleeding in burns: the effect of Cimetidine or antacids combined with early enteral feeding. Burns 12: 65CrossRefGoogle Scholar
  28. Poleski MH, Spanier AH (1986) Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol 81: 107PubMedGoogle Scholar
  29. Powell JR, Donn KH (1983) The pharmacokinetic basis of H2-antagonist drag interactions: concepts and implications. J Clin Gastroenterol 5: 95–113PubMedCrossRefGoogle Scholar
  30. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W (1980) Antacid versus Cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med 21: 426CrossRefGoogle Scholar
  31. Puurunen J, Pelkonen O (1979) Cimetidine inhibits microsomal drug metabolism in the rat. Eur J Pharmacol 55: 335–336PubMedCrossRefGoogle Scholar
  32. Schentag JJ, Cerra FB, Calleri G, DeGlopper E, Rose JQ, Bernhard H (1979) Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 27: 177–181CrossRefGoogle Scholar
  33. Schentag JJ, Cerra FB, Caller G, Leising ME, French MA, Bernhard H (1981) Age, disease, and Cimetidine disposition in healthy subjects and chronically ill patients. Clin Pharmacol Ther 29: 737–743PubMedCrossRefGoogle Scholar
  34. Schiessel R, Starlinger M, Wolf A, Pinggera W, Zazgornik J, Schnait P, Wagner O, Schwarz S, Piza F (1981) Failure of Cimetidine of prevent gastroduodenal ulceration and bleeding after renal transplantation. Surgery 90: 456–458PubMedGoogle Scholar
  35. Silvestri N, Curzio M, Motta U, DePietri P, Bonacina F, Minoja G (1980) Cimetidine to prevent stress ulcers. Lancet 1: 885PubMedCrossRefGoogle Scholar
  36. Skillman JJ, Gould SA, Chung RSK, Silen W (1970) The gastric mucosal barrier: clinical and experimental studies in critically ill and normal man and in the rabbit. Ann Surg 172: 564–584PubMedCrossRefGoogle Scholar
  37. Somogyi A, Gugler R (1982) Drug interactions with Cimetidine. Clin Pharmacokin 7: 23–41CrossRefGoogle Scholar
  38. Tryba M (1986) Streßblutungsprophylaxe — brauchen wir ein neues Konzept? Dtsch Med Wochen- schr 111: 1627–1629CrossRefGoogle Scholar
  39. Tryba M, Huchzermeyer H, Török M, Zenz M, Pahlow J (1983) Single-drug and combined medication with Cimetidine, antacids and pirenzepine in the prophylaxis of acute upper gastrointestinal bleeding. Hepatogastroenterol 30: 154–157Google Scholar
  40. Tryba M, Zevounou F, Török M (1985) Prophylaxe akuter Streßblutungen mit Cimetidin, Antazida oder Sueralfat unter einer Basismedikation von Pirenzepin. Eine kontrollierte randomisierte Studie bei 100 chirurgischen Intensivpatienten. Intensivmed 22: 315–321Google Scholar
  41. Weigelt JA, Aurbakken CM, Gewertz BL, Snyder WH (1981) Cimetidine vs antacid in prophylaxis for stress ulceration. Arch Surg 116: 597PubMedGoogle Scholar
  42. Zinner MJ, Zuidema GD, Smith PL, Mignosa M (1981) The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 153: 214–220PubMedGoogle Scholar
  43. Zumtobel V, Teichmann RK, Inthorn D (1979) Zur Prophylaxe und Therapie gastroduodenaler Streßblutungen bei Intensivpatienten mit dem Histamin-H2-Rezeptoren-Antagonisten Cimetidin. Langenbecks Archiv Chir 247Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • R. Gugler
    • 1
  1. 1.I.Medizinische KlinikKlinikum KarlsruheKarlsruheGermany

Personalised recommendations